Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy
Abstract Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression‐free survival without the adverse effects of steroid‐based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug...
Main Authors: | Rajeev Ramakrishna, Terrence H. Diamond, William Alexander, Arumugam Manoharan, Terry Golombick |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-04-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.2735 |
Similar Items
-
A noninterventional observational registry of patients with multiple myeloma treated with lenalidomide in Taiwan
by: Shang-Yi Huang, et al.
Published: (2017-09-01) -
Efficacy and tolerability of bortezomib and dexamethasone in newly diagnosed multiple myeloma
by: Mir Sadaqat Hassan Zafar, et al.
Published: (2018-01-01) -
Combined targeting of MEK and the glucocorticoid receptor for the treatment of RAS-mutant multiple myeloma
by: Priya Sriskandarajah, et al.
Published: (2020-03-01) -
Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma
by: Taleb Azarm, et al.
Published: (2012-01-01) -
Outcome of response of multiple myeloma to induction treatment in kurdistan region of Iraq
by: Akram Mahmood Mohammed, et al.
Published: (2020-01-01)